US Patent 10611750 Tetrahydroquinoline compositions as bet bromodomain inhibitors

Patent 10611750 was granted and assigned to FORMA Therapeutics on April, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

FORMA Therapeutics

Current Assignee

FORMA Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106117500

Date of Patent

April 7, 2020

Patent Application Number

162254840

Date Filed

December 19, 2018

Patent Citations

‌

US Patent 10377768 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

‌

US Patent 10336722 Tetrahydroquinoline compositions as BET bromodomain inhibitors

‌

US Patent 10377769 Benzopiperazine compositions as BET bromodomain inhibitors

Patent Citations Received

Patent Primary Examiner

‌

D Margaret M Seaman

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10611750 Tetrahydroquinoline compositions as bet bromodomain inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API